JP2021091684A - Plant extract composition and method for preparing the same - Google Patents

Plant extract composition and method for preparing the same Download PDF

Info

Publication number
JP2021091684A
JP2021091684A JP2020202787A JP2020202787A JP2021091684A JP 2021091684 A JP2021091684 A JP 2021091684A JP 2020202787 A JP2020202787 A JP 2020202787A JP 2020202787 A JP2020202787 A JP 2020202787A JP 2021091684 A JP2021091684 A JP 2021091684A
Authority
JP
Japan
Prior art keywords
plant
composition
plant extract
extract
extract composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020202787A
Other languages
Japanese (ja)
Inventor
蔡禮安
Li-An Tsai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tsai Li An
Original Assignee
Tsai Li An
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsai Li An filed Critical Tsai Li An
Publication of JP2021091684A publication Critical patent/JP2021091684A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718Coptis (goldthread)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/72Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738Rosa (rose)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

To provide a method for preparing a plant extract composition.SOLUTION: Extract from Cirsium japonicum, Glycine tomentella, Murraya paniculata, Ventilago elegans, Hibiscus mutabilis, Coptis quinquefolia Miq., Ficus formosana Maxim, Catunaregam spinosa, Ficus pumil and Ampelopsis brevipedunculata is provided, a plant composition is immersed in water, the plant composition is immersed in a first solution, and the plant composition is heated with water, resulting in a plant extract composition.SELECTED DRAWING: Figure 1

Description

本発明の目的は、抽出組成物およびその調製方法を提供することであり、具体的には、植物抽出物組成物およびその調製方法に関する。 An object of the present invention is to provide an extraction composition and a method for preparing the same, and specifically, the present invention relates to a plant extract composition and a method for preparing the same.

近年、自然への回帰を求める声が高まる中、植物抽出物への注目が高まっている。植物抽出物の定義は、世界中の国で完全に同じではないが、一般的には、植物を原料として使用し、抽出された最終製品の使用方法と使用方法に従って、物理的および化学的抽出および分離プロセスを通じて、植物内の1つ以上の有効成分を取得、濃縮することである。 In recent years, as calls for a return to nature have increased, attention has been focused on plant extracts. The definition of plant extracts is not exactly the same in countries around the world, but in general, plants are used as raw materials and physically and chemically extracted according to the usage and usage of the final product extracted. And through the separation process, one or more active ingredients in the plant are obtained and concentrated.

アロマセラピーとは、アロマ植物から抽出したエッセンシャルオイルを媒体とし、マッサージ、入浴、お香などによって気道や皮膚から体内に吸収され、精神的ストレスを和らげ、健康状態を改善する自然療法である。アロマテラピーは古代エジプトで始まり、現代ヨーロッパで人気が出てきたが、主流の医学では認められていない代替医療である。 Aromatherapy is a natural remedy that uses essential oils extracted from aroma plants as a medium and is absorbed into the body through the respiratory tract and skin by massage, bathing, incense, etc. to relieve mental stress and improve health. Aromatherapy is an alternative medicine that began in ancient Egypt and has become popular in modern Europe, but is not recognized in mainstream medicine.

植物蒸気浴とは、植物抽出物の燃焼によって生成される煙または植物抽出物の沸騰によって生成される蒸気を使用して、植物抽出物の有効成分を皮膚の毛穴や経穴に入れ、内臓に浸透させ、直接吸収により有効成分を全身に移して効果を出す方法である。蒸気浴は、皮膚に加温効果をもたらし、植物抽出物の有効成分を促進して皮膚に均一に接触し、細胞の透過性を高めるため、熱因子と霧状の有効成分が皮膚表面に吸収され、ケラチンに浸透し、真皮層で輸送され、最終的に血液循環に入り、皮膚温度を上昇させて毛細血管を拡張し、血液とリンパ循環を促進し、心臓への負担を軽減し、代謝を促進するため、植物抽出物のエッセンスの浸透効果が大幅に向上する。植物蒸気浴は、調和の取れていない臓器機能を有益に調節し、人の気分を緩和し、筋肉をリラックスさせ、それによって睡眠を改善して、生理、心理のバランスを実現するだけでなく、血液を浄化して血液粘度を減らし、血管の弾力性の増加、病気の予防、顔色の改善、血液循環障害による疲労とめまいの緩和、経絡疾患の調整など効果を実現できる。 A plant steam bath uses the smoke produced by burning the plant extract or the steam produced by the boiling of the plant extract to put the active ingredients of the plant extract into the pores and warps of the skin and penetrate the internal organs. It is a method in which the active ingredient is transferred to the whole body by direct absorption to produce an effect. The steam bath has a warming effect on the skin, promotes the active ingredient of the plant extract, makes uniform contact with the skin, and enhances the permeability of cells, so that the heat factor and the atomized active ingredient are absorbed by the skin surface. It penetrates into keratin, is transported in the dermis layer, and finally enters the blood circulation, raises the skin temperature and dilates the capillaries, promotes blood and lymph circulation, reduces the burden on the heart, and metabolizes. The penetration effect of the essence of the plant extract is greatly improved. The plant steam bath not only beneficially regulates unbalanced organ function, relaxes one's mood, relaxes muscles, thereby improving sleep and achieving a balance of physiology and psychology. It purifies blood and reduces blood viscosity, increases the elasticity of blood vessels, prevents illness, improves complexion, relieves fatigue and dizziness due to impaired blood circulation, and regulates meridian diseases.

本発明の目的は、調製された植物抽出物組成物を植物蒸気浴と組み合わせて、最良の効果を達成することである。 An object of the present invention is to combine the prepared plant extract composition with a plant vapor bath to achieve the best effect.

上記の目的を達成するために、本出願は、植物抽出物組成物およびその調製方法を提供する。植物抽出物組成物は、使用者の湿気の除去および解毒することにより、代謝の促進、体力の調節、炎症症状の軽減および創傷治癒の促進の効果を達成できる。 To achieve the above object, the present application provides a plant extract composition and a method for preparing the same. The plant extract composition can achieve the effects of promoting metabolism, regulating physical strength, reducing inflammatory symptoms and promoting wound healing by removing and detoxifying the user's moisture.

本発明の目的は、植物抽出物組成物の調製方法を提供することである。その方法は:ノアザミ(Cirsium japonicum)、ヒロハヤブマメ(Glycine tomentella)、ゲッキツ(Murraya paniculata)、カザナビキ(Ventilago elegans)、フヨウ(Hibiscus mutabilis)、バイカオウレン(Coptis quinquefolia Miq.)、タイワンイヌビワ(Ficus formosana Maxim)、ハリザクロ(Catunaregam spinosa)、オオイタビ(Ficus pumil)およびキレハノブドウ(Ampelopsis brevipedunculata)を含む植物組成物を提供するステップと、前記植物組成物を水に浸すステップと、前記植物組成物を第1の溶液に浸すステップと、前記植物組成物と水を一緒に加熱して植物抽出物組成物を得るステップとを含む。 An object of the present invention is to provide a method for preparing a plant extract composition. The method: (. Coptis quinquefolia Miq) Noazami (Cirsium japonicum), Hirohayabumame (Glycine tomentella), Murraya paniculata (Murraya paniculata), Kazanabiki (Ventilago elegans), mutabilis (Hibiscus mutabilis), Baikaouren, Taiwan Ficus (Ficus formosana Maxim), A step of providing a plant composition containing Coptis quinque (Catunaregam spinosa), a citis quinque (Ficus plumil) and a citris quinque (Ampelopsis brevipedunculata), a step of immersing the plant composition in water, and a step of immersing the plant composition in a first solution. The step includes a step of heating the plant composition and water together to obtain a plant extract composition.

より好ましくは、前記植物抽出物組成物の調製方法は、植物抽出物組成物を40〜50度の湿度下で室温まで冷却し、残留物を取り除くステップを更に含む。 More preferably, the method for preparing the plant extract composition further comprises the step of cooling the plant extract composition to room temperature under a humidity of 40 to 50 degrees Celsius to remove residues.

より好ましくは、前記水と一緒に加熱するステップは、弱火で5時間加熱することを含む。 More preferably, the step of heating with the water comprises heating on low heat for 5 hours.

より好ましくは、前記第1の溶液は、水および酢を含み、且つpH値は7.2〜7.8の間にある。 More preferably, the first solution contains water and vinegar and has a pH value between 7.2 and 7.8.

より好ましくは、前記植物組成物の中にノアザミの割合は8.0〜12.0wt.%、ヒロハヤブマメの割合は10.0〜14.0wt.%、ゲッキツの割合は10.0〜14.0wt.%、カザナビキの割合は10.0〜14.0wt.%、フヨウの割合は8.0〜12.0wt.%、バイカオウレンの割合は8.0〜12.0wt.%、タイワンイヌビワの割合は6.0〜10.0wt.%、ハリザクロの割合は7.0〜11.0wt.%、オオイタビの割合は6.0〜10.0wt.%、そしてキレハノブドウの割合は7.0〜11.0wt.%である。 More preferably, the ratio of Cirsium japonicum in the plant composition is 8.0 to 12.0 wt. %, The proportion of Hirohaya bean is 10.0 to 14.0 wt. %, The ratio of jessamine is 10.0 to 14.0 wt. %, The ratio of Kazanaviki is 10.0 to 14.0 wt. %, The ratio of Fuyo is 8.0 to 12.0 wt. %, The ratio of coptis quinque is 8.0 to 12.0 wt. %, The ratio of Taiwan Inubiwa is 6.0 to 10.0 wt. %, The ratio of Harizakuro is 7.0 to 11.0 wt. %, The ratio of Climbing fig is 6.0 to 10.0 wt. %, And the proportion of Kirehano grapes is 7.0-11.0 wt. %.

本発明のもう一つの目的は、ノアザミ抽出物、ヒロハヤブマメ抽出物、ゲッキツ抽出物、カザナビキ抽出物、フヨウ抽出物、バイカオウレン抽出物、タイワンイヌビワ抽出物、ハリザクロ抽出物、オオイタビ抽出物およびキレハノブドウ抽出物を含む植物抽出物組成物を提供することである。 Another object of the present invention is to obtain Noazami extract, Hirohayabu bean extract, Gekitsu extract, Kazanabiki extract, Fuyo extract, Baikaouren extract, Taiwan Inubiwa extract, Harizakuro extract, Oitabi extract and Kirehano grape extract. To provide a plant extract composition comprising.

より好ましくは、前記植物抽出物組成物の総イオンクロマトグラフィー(TIC)プロファイルは、2.167±0.5分、2.662±0.5分、4.203±0.5分、78.23±0.5分、79.033±0.5分、79.792±0.5分、および82.327±0.5分にピークがある。 More preferably, the total ion chromatography (TIC) profile of the plant extract composition is 2.167 ± 0.5 minutes, 2.662 ± 0.5 minutes, 4.203 ± 0.5 minutes, 78. There are peaks at 23 ± 0.5 minutes, 79.033 ± 0.5 minutes, 79.792 ± 0.5 minutes, and 82.327 ± 0.5 minutes.

より好ましくは、前記植物抽出物組成物は、図3に示される総イオンクロマトグラフィーを有する。 More preferably, the plant extract composition has total ion chromatography as shown in FIG.

より好ましくは、前記植物抽出物組成物は、植物蒸気浴用の植物抽出物組成物である。 More preferably, the plant extract composition is a plant extract composition for a plant steam bath.

上記の植物抽出物組成物を植物蒸気浴の入浴剤の形で使用すると、使用者の湿気の除去および解毒するのを助けるため、代謝の促進、体力の調節、炎症症状の軽減および創傷治癒の促進の効果を達成できる。 When the above plant extract composition is used in the form of a plant vapor bath bath salt, it helps to remove moisture and detoxify the user, thus promoting metabolism, regulating physical fitness, reducing inflammatory symptoms and healing wounds. The effect of promotion can be achieved.

添付の図面を参照した以下の詳細な説明は、当分野の技術者にとってより明白にするであろう。そのうち:
本願実施例による植物抽出物組成物の調製方法10の概略的フローチャートである。 本願実施例による植物抽出物組成物外観写真である。 本願実施例による植物抽出物組成物の総イオンクロマトグラフィーである。 使用者が植物蒸気浴を介して本願実施例による植物抽出物組成物を使用する効果図である。 使用者が植物蒸気浴を介して本願実施例による植物抽出物組成物を使用する効果図である。
The following detailed description with reference to the accompanying drawings will be more apparent to engineers in the art. Of which:
It is a schematic flowchart of the preparation method 10 of the plant extract composition according to the Example of this application. It is a photograph of the appearance of the plant extract composition according to the Example of this application. It is a total ion chromatography of the plant extract composition according to the Example of this application. FIG. 5 is an effect diagram in which a user uses a plant extract composition according to an embodiment of the present application via a plant steam bath. FIG. 5 is an effect diagram in which a user uses a plant extract composition according to an embodiment of the present application via a plant steam bath.

以下、植物抽出物組成物の調製方法の実施例について、図面を参照しながら説明するが、理解を容易にするため、以下の実施例において同一の要素には同一の符号を付している。 Hereinafter, examples of the method for preparing the plant extract composition will be described with reference to the drawings, but for ease of understanding, the same elements are designated by the same reference numerals in the following examples.

本明細書に記載される任意の数値範囲は、同じ数値精度の範囲内のすべての部分範囲を包含することが意図されている。たとえば、範囲「1.0〜10.0」は、最小値1.0と最大値10.0、および最小値1.0と最大値10.0の間のすべてのサブ範囲(つまり、最小値が1.0以上、最大値が10.0以下)を含むことを目的としている。たとえば、1.1〜8.6。本明細書に記載されている最大数の限界は、その中のすべてのより低い数値の限界を包含することを意図し、本明細書に記載されているすべての最小の数の限界は、その中のすべてのより高い数値の限界を包含することが意図されている。 Any numerical range described herein is intended to cover all subranges within the same numerical accuracy range. For example, the range "1.0 to 10.0" is all subranges between the minimum value 1.0 and the maximum value 10.0, and the minimum value 1.0 and the maximum value 10.0 (that is, the minimum value value). Is 1.0 or more and the maximum value is 10.0 or less). For example, 1.1 to 8.6. The maximum number limits described herein are intended to include all lower numerical limits therein, and all minimum number limits described herein are said to be such. It is intended to include the limits of all the higher numbers in.

本明細書で「約」と記載されている特定の値は、測定誤差による特定の値の±10%、好ましくは±5%、より好ましくは±1%、さらにより好ましくは±0.1%の差をカバーすると理解することができる。 The specific value described herein as "about" is ± 10%, preferably ± 5%, more preferably ± 1%, even more preferably ± 0.1% of the specific value due to measurement error. It can be understood that it covers the difference between.

本明細書において、「室温」とは、約20〜35℃の温度をいう。 As used herein, the term "room temperature" refers to a temperature of about 20 to 35 ° C.

本明細書において、「小火」とは、漢方薬の煎じ薬に用いられる火の一種であり、「ゆっくり火」とも呼ばれ、通常、ゆっくりと温度が上がり、水がゆっくりと蒸発する加熱方法をいう。約80〜150℃の加熱を指す。 In the present specification, "small fire" is a kind of fire used for decoction of Chinese herbs, and is also called "slow fire", and usually refers to a heating method in which the temperature rises slowly and water evaporates slowly. .. Refers to heating at about 80-150 ° C.

本明細書において、「植物蒸気浴」とは、溶液を加熱して、気体に気化させてから吸収させる投与方法を指す。 As used herein, the term "vegetable vapor bath" refers to an administration method in which a solution is heated, vaporized into a gas, and then absorbed.

図1は、本願実施例による植物抽出物組成物の調製方法10の概略的フローチャートである。図1に示されるように、植物抽出物組成物を調製するための方法10は、植物組成物を提供するステップS101と、植物組成物を水に浸すステップS103と、植物組成物を第1の溶液に浸すステップS015と、植物組成物と水を一緒に加熱して植物抽出物組成物を得るステップS107とを含む。 FIG. 1 is a schematic flowchart of a method 10 for preparing a plant extract composition according to an embodiment of the present application. As shown in FIG. 1, the method 10 for preparing the plant extract composition comprises step S101 for providing the plant composition, step S103 for immersing the plant composition in water, and first the plant composition. Includes step S015 of immersion in the solution and step S107 of heating the plant composition and water together to obtain a plant extract composition.

ステップS101において、ノアザミ、ヒロハヤブマメ、ゲッキツ、カザナビキ、フヨウ、バイカオウレン、タイワンイヌビワ、ハリザクロ、オオイタビおよびキレハノブドウを収集して洗って、本発明の植物組成物を提供する。一実施例により、流水で上記の材料を洗って、その表面にある土および不純物を除去し、より好ましくは、1分間4リトルの流量で上記材料を洗浄する。 In step S101, Cirsium japonicum, Orange jessamine, Orange jessamine, Confederate rose, Coptis quinque, Ficus erecta, Climbing fig, and Climbing fig are collected and washed to provide the plant composition of the present invention. According to one embodiment, the material is washed with running water to remove soil and impurities on its surface, more preferably at a flow rate of 4 little per minute.

一実施例により、その植物組成物の中に、ノアザミの割合は8.0〜12.0wt.%、より好ましくは9.0〜11.0wt.%、更に好ましくは10.0wt.%であり、ヒロハヤブマメの割合は10.0〜14.0wt.%、より好ましくは11.0〜13.0wt.%、更に好ましくは12.0wt.%であり、ゲッキツの割合は10.0〜14.0wt.%、より好ましくは11.0〜13.0wt.%、更に好ましくは12.0wt.%であり、カザナビキの割合は10.0〜14.0wt.%、より好ましくは11.0〜13.0wt.%、更に好ましくは12.0wt.%であり、フヨウの割合は8.0〜12.0wt.%、より好ましくは9.0〜11.0wt.%、更に好ましくは10.0wt.%であり、バイカオウレンの割合は8.0〜12.0wt.%、より好ましくは9.0〜11.0wt.%、更に好ましくは10.0wt.%であり、タイワンイヌビワの割合は6.0〜10.0wt.%、より好ましくは7.0〜9.0wt.%、更に好ましくは8.0wt.%であり、ハリザクロの割合は7.0〜11.0wt.%、より好ましくは8.0〜10.0wt.%、更に好ましくは9.0wt.%であり、オオイタビの割合は6.0〜10.0wt.%、より好ましくは7.0〜9.0wt.%、更に好ましくは8.0wt.%であり、そしてキレハノブドウの割合は7.0〜11.0wt.%、より好ましくは8.0〜10.0wt.%、更に好ましくは9.0wt.%である。しかし、本発明はこれに限定されない。 According to one example, the proportion of Cirsium japonicum in the plant composition is 8.0-12.0 wt. %, More preferably 9.0 to 11.0 wt. %, More preferably 10.0 wt. %, And the proportion of hirohayabume is 10.0 to 14.0 wt. %, More preferably 11.0 to 13.0 wt. %, More preferably 12.0 wt. %, And the proportion of jessamine is 10.0 to 14.0 wt. %, More preferably 11.0 to 13.0 wt. %, More preferably 12.0 wt. %, And the proportion of Kazanaviki is 10.0 to 14.0 wt. %, More preferably 11.0 to 13.0 wt. %, More preferably 12.0 wt. %, And the proportion of Fuyo is 8.0 to 12.0 wt. %, More preferably 9.0 to 11.0 wt. %, More preferably 10.0 wt. %, And the proportion of coptis quinque is 8.0 to 12.0 wt. %, More preferably 9.0 to 11.0 wt. %, More preferably 10.0 wt. %, And the ratio of Taiwan Ficus erecta is 6.0 to 10.0 wt. %, More preferably 7.0-9.0 wt. %, More preferably 8.0 wt. %, And the proportion of Hari pomegranate is 7.0 to 11.0 wt. %, More preferably 8.0 to 10.0 wt. %, More preferably 9.0 wt. %, And the proportion of figs is 6.0 to 10.0 wt. %, More preferably 7.0-9.0 wt. %, More preferably 8.0 wt. %, And the proportion of Kirehano grapes is 7.0-11.0 wt. %, More preferably 8.0 to 10.0 wt. %, More preferably 9.0 wt. %. However, the present invention is not limited to this.

ステップS103において、上記ステップS101が提供した植物組成物を水に浸して水溶性有毒物を更に除去し、そして、水溶性有毒物が除去された植物組成物をステップS105の浸すを実行する。 In step S103, the plant composition provided in step S101 is immersed in water to further remove the water-soluble toxic substance, and the plant composition from which the water-soluble toxic substance has been removed is immersed in step S105.

ステップS105において、水溶性有毒物が除去された植物組成物を第1の溶液に浸して軟化させることにより、後の工程で植物組成物中の有効成分を抽出しやすくなる。使用する第1の溶液のpH値は約7.2〜7.8で、酢と純水が含まれている。ステップS105における浸漬時間は、約20〜30時間、好ましくは22〜28時間、より好ましくは24時間とすることができる。 In step S105, by immersing the plant composition from which the water-soluble toxic substance has been removed in the first solution to soften it, the active ingredient in the plant composition can be easily extracted in a later step. The first solution used has a pH value of about 7.2-7.8 and contains vinegar and pure water. The immersion time in step S105 can be about 20 to 30 hours, preferably 22 to 28 hours, more preferably 24 hours.

最後に、ステップS107において、浸漬および軟化された植物組成物および水を、約2〜6時間、好ましくは3〜5時間、より好ましくは5時間、小火で加熱して、本発明の植物抽出物組成物を得る。 Finally, in step S107, the soaked and softened plant composition and water are heated on a small fire for about 2-6 hours, preferably 3-5 hours, more preferably 5 hours to extract the plants of the present invention. Obtain the composition.

一実施例において、本発明の植物抽出物組成物は、40〜50度の湿度下で室温まで冷却され、その後、残留物を取り除いて保管することができ、セラミックまたはガラス材料の容器に保管するのがよい。上記の方法に従って得られた本発明の植物抽出物組成物は、図2に示すように、黄褐色の液体である。図2は、本発明の実施例による植物抽出物組成物の外観の写真である。 In one example, the plant extract composition of the present invention is cooled to room temperature under a humidity of 40-50 ° C., after which the residue can be removed and stored and stored in a container of ceramic or glass material. Is good. The plant extract composition of the present invention obtained according to the above method is a yellowish brown liquid as shown in FIG. FIG. 2 is a photograph of the appearance of the plant extract composition according to the embodiment of the present invention.

上記の方法に従って得られた本発明の植物抽出物組成物を、Agilent 7890BガスクロマトグラフおよびAgilent 5977A質量分析計により、以下のパラメーターでGC/MS分析を実行する:注入量:1μl;注入温度:280°C;キャリアガス:He;カラム:DB−5MS30m*0.25mm*0.25μm;カラム流量:1.0mL/min;イオン源温度(MSソース温度):230℃;クワッド温度(MAクワッド温度):150℃;MSスキャン範囲:40m/z〜550m/z;そして、GCオーブン加熱プログラムを以下の表1に示す。

Figure 2021091684
The plant extract composition of the present invention obtained according to the above method is subjected to GC / MS analysis by an Agilent 7890B gas chromatograph and an Agilent 5977A mass spectrometer with the following parameters: injection volume: 1 μl; injection temperature: 280. ° C; Carrier gas: He; Column: DB-5MS 30m * 0.25mm * 0.25μm; Column flow rate: 1.0mL / min; Ion source temperature (MS source temperature): 230 ° C.; Quad temperature (MA quad temperature) : 150 ° C .; MS scan range: 40 m / z to 550 m / z; and the GC oven heating program is shown in Table 1 below.
Figure 2021091684

高濃度の標準液として、0.01gのメンソールを使用して、メタノールを10mL(濃度1000μg/mL)まで定量する。10μLの高濃度標準溶液を使用して、低濃度標準溶液としてメタノール(濃度10μg/mL)で1mLに定量化する。そして、分析のために、本発明の実施例の植物抽出物組成物1.0232gを10mLに定量化する。得られた結果は、100ppmメンソールの面積値でのピーク値に対する相対定量を実行し、相対定量のパーセンテージを取得できる。結果を図3に示す。 Methanol is quantified to 10 mL (concentration 1000 μg / mL) using 0.01 g menthol as a high concentration standard solution. Quantify to 1 mL with methanol (concentration 10 μg / mL) as a low concentration standard solution using 10 μL high concentration standard solution. Then, for analysis, 1.0232 g of the plant extract composition of the example of the present invention is quantified to 10 mL. The results obtained can be subjected to relative quantification with respect to the peak value at the area value of 100 ppm menthol to obtain the percentage of relative quantification. The results are shown in FIG.

図3は、SGS HPLC質量分析後に得られた、本発明の実施例の植物抽出物組成の全イオンクロマトグラフィー(TIC)スペクトルである。図3からわかるように、本発明の実施例の植物抽出物組成には、2.167±0.5分、2.662±0.5分、4.203±0.5分、78.23±0.5分、79.033±0.5分、79.792±0.5分、82.327±0.5分にピーク値がある。 FIG. 3 is a total ion chromatography (TIC) spectrum of the plant extract composition of the examples of the present invention obtained after SGS HPLC mass spectrometry. As can be seen from FIG. 3, the plant extract composition of the examples of the present invention includes 2.167 ± 0.5 minutes, 2.662 ± 0.5 minutes, 4.203 ± 0.5 minutes, 78.23. There are peak values at ± 0.5 minutes, 79.033 ± 0.5 minutes, 79.792 ± 0.5 minutes, and 82.327 ± 0.5 minutes.

図3からわかるように、新しく合成された分子化合物は、自然界の植物で10種類を超える触媒イオン化を使用して得られた本発明の実施例の植物抽出物組成物に含まれている。次の表2〜4は、SGS HPLC質量分析後に得られた本発明の実施例の植物抽出物組成の成分の一部を示す。

Figure 2021091684
Figure 2021091684
Figure 2021091684
As can be seen from FIG. 3, the newly synthesized molecular compound is contained in the plant extract composition of the examples of the present invention obtained by using more than 10 kinds of catalytic ionization in plants in nature. Tables 2-4 below show some of the components of the plant extract composition of the examples of the present invention obtained after SGS HPLC mass spectrometry.
Figure 2021091684
Figure 2021091684
Figure 2021091684

上記の表2〜4から、本発明の実施例の植物抽出物組成物は、3−ヒドロキシブタノン、クラウンエーテル−5、ピルビン酸、メトキシエチルアミン、トリエチルホスフィン、バリン酸、シクロペンタジオン、2−ヒドロキシ−2−シクロペンテン−1−オン、ステアリン酸、およびアルコールを含む。その中、Crown−5(クラウン−5)は、水分を吸収しやすく、水と混和しやすいという特徴があり、カリウム/ナトリウムイオンに対する選択的な錯化力が強く、細胞膜に出入りできる効率的な相間移動触媒としての効果を持っている。したがって、本実施形態の植物抽出物組成物中の他の有効成分を効果的に人体の循環に取り込むことができ、吸収を促進して所望の効果を向上させることができる。ピルビン酸は、体内の酸素フリーラジカルの酸化を抑制し、フリーラジカルの損傷を防ぐ効果があり、心臓の再灌流障害や急性腎不全の際の機能的損傷から体を保護する効果がある。バリンは必須アミノ酸であり、筋肉の代謝を促進し、筋肉の協調を改善し、脳力を促進し、気分を安定させ、創傷治癒の治療を加速することができる。ステアリン酸は酸化を防止することができる。 From Tables 2-4 above, the plant extract compositions of the examples of the present invention are 3-hydroxybutanone, crown ether-5, pyruvic acid, methoxyethylamine, triethylphosphine, valine acid, cyclopentadione, 2-hydroxy. Includes -2-cyclopentene-1-one, stearic acid, and alcohol. Among them, Crown-5 has the characteristics that it easily absorbs water and is easily mixed with water, has a strong selective complexing power for potassium / sodium ions, and is efficient in entering and exiting the cell membrane. It has an effect as a phase transfer catalyst. Therefore, other active ingredients in the plant extract composition of the present embodiment can be effectively incorporated into the circulation of the human body, and absorption can be promoted to improve the desired effect. Pyruvic acid has the effect of suppressing the oxidation of oxygen free radicals in the body, preventing damage to free radicals, and protecting the body from functional damage during cardiac reperfusion injury and acute renal failure. Valine is an essential amino acid that can promote muscle metabolism, improve muscle coordination, promote brain strength, stabilize mood and accelerate wound healing treatment. Stearic acid can prevent oxidation.

本発明の実施例の植物抽出物組成物に含まれる成分によれば、本発明の実施例の植物抽出物組成物が植物蒸気浴により使用される場合、使用者の湿気の除去および解毒するのを助けるため、代謝の促進、体力の調節、炎症症状の軽減および創傷治癒の促進の効果を達成できる。 According to the components contained in the botanical extract composition of the examples of the present invention, when the botanical extract composition of the examples of the present invention is used by a plant steam bath, it removes moisture and detoxifies the user. It can achieve the effects of promoting metabolism, regulating physical strength, reducing inflammatory symptoms and promoting wound healing.

図4および図5は、使用者がこの場合の実施形態の植物抽出物組成物を植物蒸気浴の形で使用した後の効果図である。図4のパート(a)は、使用者が本発明の実施例の植物抽出物組成物をまだ使用していない状況を示している。図4のパート(b)から(f)は、植物蒸気浴により実施例の植物抽出物組成物を使用した時間の長さを順に示している。図4のパート(b)は、使用者が本発明の実施例の植物抽出物組成物を最短時間で使用したことを示している。図4のパート(f)は、使用者が本発明の実施例の植物抽出物組成物を最も長い時間使用していることを示している。図4から、この実施例の植物抽出物組成物の解毒および除湿効果により、使用者の創傷治癒が加速されることが明確に分かる。図5のパート(a)は、使用者が本発明の実施例の植物抽出物組成物をまだ使用していない状況を示している。図5のパート(b)は、使用者が植物蒸気浴の形で本発明の実施例の植物抽出物組成物を使用した後の結果を示している。図5から、植物蒸気浴の形でこの実施例の植物抽出物組成物を使用すると、浮腫および除湿を除去する効果があることが明らかに分かる。 4 and 5 are effect diagrams after the user uses the plant extract composition of the embodiment in this case in the form of a plant vapor bath. Part (a) of FIG. 4 shows a situation in which the user has not yet used the plant extract composition of the embodiment of the present invention. Parts (b) to (f) of FIG. 4 show in order the length of time that the plant extract composition of the example was used in the plant steam bath. Part (b) of FIG. 4 shows that the user used the plant extract composition of the embodiment of the present invention in the shortest time. Part (f) of FIG. 4 shows that the user has been using the plant extract composition of the examples of the present invention for the longest time. From FIG. 4, it is clearly seen that the detoxifying and dehumidifying effects of the plant extract composition of this example accelerate the wound healing of the user. Part (a) of FIG. 5 shows a situation in which the user has not yet used the plant extract composition of the embodiment of the present invention. Part (b) of FIG. 5 shows the results after the user has used the plant extract composition of the examples of the present invention in the form of a plant vapor bath. From FIG. 5, it is clear that the use of the plant extract composition of this example in the form of a plant steam bath has the effect of removing edema and dehumidification.

上記の説明は単なる例示であり、限定的なものではない。本発明の範囲及び趣旨を逸脱することなく均等範囲内における変更及び修正は、いずれも添付の特許請求の範囲で扱うものとする。 The above description is merely an example and is not limiting. Any changes or amendments within the equivalent scope without departing from the scope and gist of the present invention shall be dealt with within the scope of the appended claims.

10…植物抽出物組成物の調製方法
S101〜S107…ステップ
10 ... Method for preparing plant extract composition S101-S107 ... Step

Claims (9)

ノアザミ(Cirsium japonicum)、ヒロハヤブマメ(Glycine tomentella)、ゲッキツ(Murraya paniculata)、カザナビキ(Ventilago elegans)、フヨウ(Hibiscus mutabilis)、バイカオウレン(Coptis quinquefolia Miq.)、タイワンイヌビワ(Ficus formosana Maxim)、ハリザクロ(Catunaregam spinosa)、オオイタビ(Ficus pumil)およびキレハノブドウ(Ampelopsis brevipedunculata)を含む植物組成物を提供するステップと、前記植物組成物を水に浸すステップと、前記植物組成物を第1の溶液に浸すステップと、前記植物組成物と水を一緒に加熱して植物抽出物組成物を得るステップとを含むことを特徴とする、植物抽出物組成物の調製方法。 Noazami (Cirsium japonicum), Hirohayabumame (Glycine tomentella), Murraya paniculata (Murraya paniculata), Kazanabiki (Ventilago elegans), cotton rose (Hibiscus mutabilis), Baikaouren (Coptis quinquefolia Miq.), Taiwan Ficus (Ficus formosana Maxim), Harizakuro (Catunaregam spinosa ), A step of providing a plant composition containing Ficus plum and a step of immersing the plant composition in water, a step of immersing the plant composition in a first solution, and the above. A method for preparing a plant extract composition, which comprises a step of heating the plant composition and water together to obtain a plant extract composition. 植物抽出物組成物を40〜50度の湿度下で室温まで冷却し、残留物を取り除くステップを更に含むことを特徴とする、請求項1に記載の植物抽出物組成物の調製方法。 The method for preparing a plant extract composition according to claim 1, further comprising a step of cooling the plant extract composition to room temperature under a humidity of 40 to 50 ° C. to remove residues. 前記水と一緒に加熱するステップは、弱火で5時間加熱することを含むことを特徴とする、請求項1に記載の植物抽出物組成物の調製方法。 The method for preparing a plant extract composition according to claim 1, wherein the step of heating with water includes heating on low heat for 5 hours. 前記第1の溶液は、水および酢を含み、且つpH値は7.2〜7.8の間にあることを特徴とする、請求項1に記載の植物抽出物組成物の調製方法。 The method for preparing a plant extract composition according to claim 1, wherein the first solution contains water and vinegar, and the pH value is between 7.2 and 7.8. 前記植物組成物の中にノアザミの割合は8.0〜12.0wt.%、ヒロハヤブマメの割合は10.0〜14.0wt.%、ゲッキツの割合は10.0〜14.0wt.%、カザナビキの割合は10.0〜14.0wt.%、フヨウの割合は8.0〜12.0wt.%、バイカオウレンの割合は8.0〜12.0wt.%、タイワンイヌビワの割合は6.0〜10.0wt.%、ハリザクロの割合は7.0〜11.0wt.%、オオイタビの割合は6.0〜10.0wt.%、そしてキレハノブドウの割合は7.0〜11.0wt.%であることを特徴とする、請求項1に記載の植物抽出物組成物の調製方法。 The ratio of Cirsium japonicum in the plant composition is 8.0 to 12.0 wt. %, The proportion of Hirohaya bean is 10.0 to 14.0 wt. %, The ratio of jessamine is 10.0 to 14.0 wt. %, The ratio of Kazanaviki is 10.0 to 14.0 wt. %, The ratio of Fuyo is 8.0 to 12.0 wt. %, The ratio of coptis quinque is 8.0 to 12.0 wt. %, The ratio of Taiwan Inubiwa is 6.0 to 10.0 wt. %, The ratio of Harizakuro is 7.0 to 11.0 wt. %, The ratio of Climbing fig is 6.0 to 10.0 wt. %, And the proportion of Kirehano grapes is 7.0-11.0 wt. The method for preparing a plant extract composition according to claim 1, wherein the composition is%. ノアザミ抽出物、ヒロハヤブマメ抽出物、ゲッキツ抽出物、カザナビキ抽出物、フヨウ抽出物、バイカオウレン抽出物、タイワンイヌビワ抽出物、ハリザクロ抽出物、オオイタビ抽出物およびキレハノブドウ抽出物を含むことを特徴とする、植物抽出物組成物。 A plant extract characterized by containing Cirsium japonicum extract, Hirohaya bean extract, Gekkitsu extract, Kazanabiki extract, Fuyo extract, Coptis quinque extract, Taiwan Inubiwa extract, Harizakuro extract, Oitabi extract and Kirehano grape extract. Product composition. 前記植物抽出物組成物の総イオンクロマトグラフィー(TIC)プロファイルは、2.167±0.5分、2.662±0.5分、4.203±0.5分、78.23±0.5分、79.033±0.5分、79.792±0.5分、および82.327±0.5分にピークがあることを特徴とする、請求項6に記載の植物抽出物組成物。 The total ion chromatography (TIC) profile of the plant extract composition was 2.167 ± 0.5 minutes, 2.662 ± 0.5 minutes, 4.203 ± 0.5 minutes, 78.23 ± 0. The plant extract composition according to claim 6, characterized by peaks at 5 minutes, 79.033 ± 0.5 minutes, 79.792 ± 0.5 minutes, and 82.327 ± 0.5 minutes. Stuff. 前記植物抽出物組成物は、図3に示される総イオンクロマトグラフィーを有することを特徴とする、請求項6に記載の植物抽出物組成物。 The plant extract composition according to claim 6, wherein the plant extract composition has total ion chromatography shown in FIG. 前記植物抽出物組成物は、植物蒸気浴用の植物抽出物組成物であることを特徴とする、請求項6に記載の植物抽出物組成物。

The plant extract composition according to claim 6, wherein the plant extract composition is a plant extract composition for a plant steam bath.

JP2020202787A 2019-12-10 2020-12-07 Plant extract composition and method for preparing the same Pending JP2021091684A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TW108145157 2019-12-10
TW108145157A TW202122102A (en) 2019-12-10 2019-12-10 Plant extracts and preparation method thereof

Publications (1)

Publication Number Publication Date
JP2021091684A true JP2021091684A (en) 2021-06-17

Family

ID=75962640

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020202787A Pending JP2021091684A (en) 2019-12-10 2020-12-07 Plant extract composition and method for preparing the same

Country Status (4)

Country Link
JP (1) JP2021091684A (en)
CN (1) CN112933148A (en)
DE (1) DE102020127448A1 (en)
TW (1) TW202122102A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102106422B (en) * 2009-12-23 2012-12-19 海南大学 Method for preparing murraya paniculata tea
CN102274288B (en) * 2010-06-09 2013-07-17 台湾糖业股份有限公司 Application of ficus formosana maxim extract as drug for preventing skin aging
CN103393953B (en) * 2013-08-18 2014-12-24 郝学江 Traditional Chinese medicine ointment for promoting postoperative wound healing, and preparation method thereof

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
HUANG, G. J. ET AL.: "Bioassay guided isolation and identification of anti-inflammatory active compounds from the root of", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 61, no. 46, JPN6021048060, 2013, pages 11008 - 11015, ISSN: 0004806002 *
IKUTA AKIRA, ITOKAWA HIDEJI: "Protoberberine Alkaloids from Coptis quinqnefolia", 生薬学雑誌, vol. 第43巻, 第1号, JPN6021048061, 1989, pages 81 - 82, ISSN: 0004806001 *
LAI, W. C. ET AL.: "Bioactive constituents of Cirsium japonicum var. australe", JOURNAL OF NATURAL PRODUCTS, vol. 77, no. 7, JPN6021048067, 2014, pages 1624 - 1631, XP055884475, ISSN: 0004805996, DOI: 10.1021/np500233t *
LE, M. Q. ET AL.: "The Water-extracted Ampelopsis brevipedunculata downregulates IL-1β,CCL5, and COX-2 expression via", JOURNAL OF PHARMACOLOGICAL SCIENCES, vol. 126, no. 4, JPN6021048052, 2014, pages 359 - 369, ISSN: 0004806005 *
LIAO, C. R. ET AL.: "Analgesic and Anti-Inflammatory Activities of Methanol Extract of Ficus pumila L. in Mice", EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, vol. 2012, JPN6021048053, 2012, pages 340141 - 9, ISSN: 0004806004 *
LIN, C. C. ET AL.: "Hepatoprotective effects of emodin from Ventilago leiocarpa", JOURNAL OF ETHNOPHARMACOLOGY, vol. 52, no. 2, JPN6021048063, 1996, pages 107 - 111, ISSN: 0004805999 *
LU, T. C. ET AL.: "Analgesic and anti-inflammatory activities of aqueous extract from Glycine tomentella root in mice", JOURNAL OF ETHNOPHARMACOLOGY, vol. 113, no. 1, JPN6021048066, 2007, pages 142 - 148, XP022162828, ISSN: 0004805997, DOI: 10.1016/j.jep.2007.05.024 *
MD. RAHMAN, A. ET AL.: "Antidiarrhoeal and Anti-Inflammatory Activities of Murraya Paniculata (L.) Jack", PHARMACOLOGYONLINE, vol. 3, JPN6021048065, pages 768 - 776, ISSN: 0004805998 *
SAINI, H. ET AL.: "Anti-Inflammatory, Analgesic and Antipyretic Activity of Catunaregam spinosa (Thumb.) Tirveng Extrac", JOURNAL OF DRUG DELIVERY AND THERAPEUTICS, vol. 9, no. 5, JPN6021048057, September 2019 (2019-09-01), pages 89 - 94, ISSN: 0004806003 *
WANG, J. ET AL.: "In vitro anti-inflammatory mechanism of Folium Hibisci Mutabilis leaves ethanol extracts", AFRICAN JOURNAL OF TRADITIONAL, COMPLEMENTARY, AND ALTERNATIVE MEDICINES, vol. 11, no. 1, JPN6021048062, 2013, pages 127 - 130, ISSN: 0004806000 *
張 建雄 ほか: "台湾産生薬「黄金桂」の生薬学的研究", 生薬学雑誌, vol. 第47巻, 第4号, JPN6021048050, 1993, pages 377 - 387, ISSN: 0004806006 *
編集代表 津田 恭介・野上 寿, 医薬品開発基礎講座 XI 薬剤製造法(上), JPN6020013236, 10 July 1971 (1971-07-10), pages 1 - 25, ISSN: 0004806007 *

Also Published As

Publication number Publication date
DE102020127448A1 (en) 2021-06-10
CN112933148A (en) 2021-06-11
TW202122102A (en) 2021-06-16

Similar Documents

Publication Publication Date Title
CN102397182B (en) Compound essential oil for improving skin properties
CN103816295B (en) Formula and preparation method for health-maintaining line incense
CN103007104A (en) Compound Chinese mugwort essential oil
CN110403869A (en) A kind of plant is releived composite essential oil and preparation method thereof
CN106137801A (en) A kind of plants essential oil balsam and preparation method thereof
KR20070112935A (en) Herb medicine composition and the method manufacture thereof
CN104984275A (en) Foot bath health-care traditional Chinese medicine benefiting Qi and activating blood
CN103925774A (en) Drying method capable of fully exerting health care function of redwood furniture
CN104288821A (en) Smoke-free incense suitable for use in closed room, and preparation method thereof
JP2021091684A (en) Plant extract composition and method for preparing the same
CN106668294A (en) Salvia miltiorrhiza leaf composite healthcare tea having efficacies for reducing blood glucose, reducing blood fat and lowering blood pressure and preparation method and use of salvia miltiorrhiza composite leaf healthcare tea
KR20090037179A (en) Mixed flower-flavored green tea with excellent preference and preparing method thereof
KR100289111B1 (en) Process for lowering nicotine contents in tobacco
CN107594762A (en) A kind of processing method for preventing and treating beriberi insoles
KR101715076B1 (en) method of manufacturing and Functional shampoo a main material for A.gramineus
KR100839663B1 (en) A cylindrical moxa cautery bar for assiting medical treatment of otorhinolaryngological disease and a preparation method thereof
KR20120085219A (en) Method for making the black polygonatum officinale
KR20100020700A (en) Moxa and manufacturing method thereof
KR20060022214A (en) Manufacturing method of combustion and bath material of moxibustion and incense using lead
CN104739952A (en) Compound tea tree essential oil with effect of promoting wound healing
CN104431085A (en) Tea mixed with tea tree roots and preparation method of tea
CN108888700A (en) A kind of ointment and preparation method thereof
KR20040001513A (en) Deodorizing agent composition for removing and treating bad smell from human body, and deodorizing agent produced therefrom
CN104274856A (en) Incense for improving haze air and preparation method thereof
CN109157637A (en) A kind of children's medicine moxibustion item and preparation method thereof

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210224

AA79 Non-delivery of priority document

Free format text: JAPANESE INTERMEDIATE CODE: A24379

Effective date: 20210414

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211203

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220622